The controversial debate regarding the safety of vaccinations continues to captivate the masses; however we must understand whether the side effects from the vaccine outweigh the risk of the disease it may prevent. There is only one way to prevent the disease cervical cancer, and that is through examination, not vaccination. The vaccination available to aid in prevention of cervical cancer has some effectiveness and in many cases ineffectiveness, in preventing Human Papillomavirus. In essence, the most reliable method of prevention is regular visits with your physician. Gardasil is a vaccine used to prevent certain strains of Human Papillomavirus, or HPV; which may lead to cervical cancer. Although Gardasil has been available since 2006; there is concern about its validity as a prophylactic measure against HPV. With no long term research on the efficacy of this vaccination and the growing list of side effects; there …show more content…
Merck, the makers of Gardasil states “GARDASIL may not fully protect everyone, nor will it protect against diseases caused by other HPV types or against diseases not caused by HPV. GARDASIL does not prevent all types of cervical cancer, so future cervical cancer screenings will be important for your daughter.” Regular pelvic examinations are critical for optimum health; these simple routine examinations are what save lives. It takes many years for cervical cancers to progress, (ACOG, 2015) if seen regularly by your physician, these cell changes can be detected and treatment can begin accordingly. Early detection has proven to be a key factor in prevention of cervical cancer and the only way to prevent cervical cancer is a regular pelvic examination. In many cases High-risk HPV infections are asymptomatic and disappear on their own within 2 years (NCI, 2015) but again, this will be determined by a physician at a regular examination
If you have had the HPV vaccine, you should still be screened for cervical cancer and follow normal screening recommendations.
Unfortunately, there is not a vaccination to protect against every type of cancer. However, the Gardasil vaccine guards against certain strands of HPV that cause 70% of cervical cancers in women. When caught early, the Human papillomavirus is treatable, but after the virus has developed into cancer, there is no cure. Therefore, the person affected begins a painful, uncertain journey to try to save her life. The Encyclopedia of Women’s Health states, “Human papillomavirus (HPV) infection may be the most common viral sexually transmitted disease (STD) in this country. As many as 30 million Americans are infected with HPV, and each year, an additional 1 million people become infected.” (“Human Papillomavirus”). When this many people are affected by a disease that can become cancer, it would be doltish not to use available resources to prevent it. “Nationally and internationally, the HPV vaccine will significantly
Many parents would take interest in a vaccine that promises protection against the second most common form of cancer found in women each year. Especially when 11,000 women will become diagnosed with cervical cancer each year, and 3,700 of those women will die as a result. Gardasil is a vaccine given in a series of three shots to girls ranging from nine to 26 years of age. Those three shots offer protection against four different strains of the human papilloma virus, which causes cervical cancer. (“GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant].”) Without a doubt, most parents would not hesitate to have their daughters vaccinated. Unfortunately, many parents do not consider the consequences
Gardasil has been tested in thousands of women and found to be nearly 100% effective in protecting against diseases caused by the four HPV types. Side effects are very uncommon and the occurrence is about 1%. Not only are HPV vaccinations safe, and effective but in today’s society it seems that they have become necessary. “An estimated 493,000 cervical cancer cases occur each year with 274,000 deaths. More than 80% of cervical cancer deaths worldwide occur in developing countries. Cervical cancer is the second most common cancer in women”. If there is a cure of this kind of epidemic, it is evident that it is necessary.
Prophylactic vaccination against high risk human papilloma virus 16 and 18 represents an exciting means of protection against HPV related malignancy. However, this strategy alone, even if there is a level of cross protection against other oncogenic viruses, cannot completely prevent cervical cancer. In some countries cervical screening programs have reduced the incidence of invasive cervical cancer by up to 80 percent although this decline has now reached a plateau with current cancers occurring in patients who have failed to attend for screening or where the sensitivity of the tests have proved inadequate. Cervical screening is inevitably associated with significant anxiety for the many women who require investigation and treatment following abnormal cervical cytology. However, it is vitally important to stress the need for continued cervical screening to complement vaccination in order to optimize prevention in vaccines and prevent cervical cancer in older women where the value of vaccination is currently unclear. It is likely that vaccination will ultimately change the natural history of HPV disease by reducing the influence of the highly oncogenic types HPV 16 and 18. In the long term this is likely to lead to an increase in recommended screening intervals. HPV vaccination may also reduce
The medication Gardasil has proven to be safe for preventing cervical cancer, and has grown in popularity since its development. As of 2009, a grand total of 40 million
Cervical cancer is a type of abnormal and malignant cell growth on the cervix (birth canal), which causes the common death for American Women. Infected by Human Papillomavirus (HPV) through sexual contact is the main contributor to cervical cancer. According to American Cancer Society’s (ACS) (2017) estimation, around 12,820 people will newly have cervical cancer and about 4,210 people will die from that in 2017. Therefore, it is urgent to decrease the rate of cervical cancer at women. A three-shot Gardasil series vaccine approved by the FDA for girls started to prevent cervical cancer in 2006. There are more than forty types of HPVs and the majority
What if a young girl cannot afford or choice not to get the vaccine what is the outcome for them, and then if girls get the vaccine can it really stop young girls from getting Cervical cancer. Adams discuss that “ Cervical Cancer is prevented in a hundred other ways, including adequate sunlight exposure and vitamin D consumption, supplementation with probiotics, adequate intake of selenium and zinc, increased consumption of trace minerals and iodine, regular physical exercise and many other safe, natural, non-patented strategies” (447). Does anyone know really if the HPV vaccine will really stop the profit of cervical cancer? The Center of Disease control and Prevention: reported that the number of new cases has fallen to about 50,000 in 2005 according to Morbidity and Mortality Weekly report of March 16 (449). Allen points out that the women who did receive the vaccine had no major side effects. In other case Cervical Cancer strikes 14,000 American women each year killing one-fourth of them (449). If a young girl, a parent doesn’t want their daughter to get the vaccine or even has second thought about it, they should make a doctor appointment yearly to check for Cervical cancer. Then the next thing to do if the young lady does need the HPV vaccine is learn more about the vaccine and decided if they want to go in that direction for their daughter.
In June 2006, Gardasil, a Human Papillomavirus vaccine made by Merck & Co., was licensed for use and brought to the market (“HPV Vaccine”). Gardasil, which is given into a series of three injections, targets the main types of HPV. The types targeted are HPV 6, HPV 11, HPV 16 and HPV 18, which cause ninety percent of the genital warts and are the leading causes of cervical cancer (“Cervical Cancer Symptoms, Causes, Treatments”). Brought to the attention by researchers “combined, those strains affect an estimated 3 million women in the U.S” (“HPV Vaccine”). Since HPV is so common in the United States, the makers of Gardasil are trying to get a law approved that will make the shots mandatory. In 2006,
HPV vaccination is the most common used method for preventing cervical cancer in young girls ranging from age nine to eleven years old. The overall perception of the vaccine is positive by the public because of its wide use and support by state laws, school systems and medical associations. According to the American Pediatric Association the vaccine has an excellent safety record. (Nirvi,1) A reasonable amount of parents still feel skeptical about mandatory HPV vaccination on their kids and lack great knowledge regarding the vaccine’s effectiveness.
The authors appreciated the fact that Canada recently approved the use of the vaccine for males, which should decrease cervical, penile, and anal cancer rates and help in cost-savings. Unfortunately, the awareness of the new HPV vaccines remains low despite its efficacy and a small number of adverse
Cervical cancer is met with a vaccine with both pros and cons to suppress and annihilate it indefinitely. Although both Mike Adams and Arthur Allen inform the audience of the HPV vaccine, Adams vigorously argues, without evidence, that the vaccine is dangerous to humans while Allen is more sedate and discusses opposing sides to the vaccine. The HPV vaccine has its pros and cons to people that it has created debates to come down to the conclusion of a better solution for the drug companies and the people forcing to receive it. Though the HPV vaccine promises to cure cervical cancer, it has received its fair share of criticism.
Among the many arguments for mandatory HPV vaccination, the foremost is that it is an important medical achievement and a major public health milestone. This vaccine has proven to be one-hundred percent effective in preventing the 4 HPV strains that are responsible for seventy percent of cervical cancers and ninety percent of genital warts. In addition, no serious side effects have been identified. Because this vaccine is a preventive measure, administration before onset of sexual activity is ideal; however, even females who have been sexually active can still benefit from this vaccination (Perkins et al., 2010). Nationally and internationally, the HPV vaccine will significantly reduce disease burden by reducing monetary and psychological costs of invasive procedures that remove precancerous and cancerous lesions. By combining vaccination with routine Pap smear screening, these public health efforts have the remarkable opportunity to eradicate cervical cancer (Ramet et al., 2011).
In addition, the immune system of most women will usually suppress or eliminate HPVs. This is very important because only an ongoing persistent infection has the potential to lead to cervical cancer (HPV). Eleven thousand cases of this kind of cancer were confirmed in 2007 in the United States; the amount undiagnosed is still unclear but believed to be in the tens of thousands. But to give some perspective of the problem you need to understand its effects on a global level. On the world wide scale cervical cancer strikes nearly half a million women each year, claiming more than a quarter of a million lives. “High risk” HPV types 16 and 18 are implicated in Seventy percent of cervical cancers and are hence selected for vaccine targets (The HPV).
The HPV vaccine is cancer prevention. Over thousands of cases of HPV cancers are detected every year in men and women. The HPV vaccination is important because it can prevent these cancers. The United States Food and Drug Administration approved this vaccine and it is one hundred percent safe. This vaccine is preventive care for the second leading cancer in women. It has been proven to be one hundred percent effective in prevention of cervical cancer, but the vaccine must be given to children between the age of 11 -17 before they become sexually active. After the age seventeen with young women most become sexually active and receive their first pap smear from their gynecologist, receiving the vaccine at this point is not as effective in prevention of cancers. Another benefit of receiving the vaccine during adolescent, is it supports people who may not have the medical knowledge or access to regular medical services.